Evidence map›Paper›PMID 35335232›Full record

ArticleMolecules (Basel, Switzerland)2022

Biophysical, Biochemical, and Molecular Docking Investigations of Anti-Glycating, Antioxidant, and Protein Structural Stability Potential of Garlic.

Mohd W A Khan, Ahmed A Otaibi, Abdulmohsen K D Alsukaibi, Eida M Alshammari, Salma A Al-Zahrani, Subuhi Sherwani, Wahid A Khan, Ritika Saha, Smita R Verma, Nessar Ahmed

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Effects ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Mohd W A KhanDepartment of Chemistry, College of Sciences, University of Ha'il, Ha'il 2440, Saudi Arabia.
Ahmed A OtaibiDepartment of Chemistry, College of Sciences, University of Ha'il, Ha'il 2440, Saudi Arabia.
Abdulmohsen K D AlsukaibiDepartment of Chemistry, College of Sciences, University of Ha'il, Ha'il 2440, Saudi Arabia.
Eida M AlshammariDepartment of Chemistry, College of Sciences, University of Ha'il, Ha'il 2440, Saudi Arabia.ORCID 0000-0003-2948-5040
Salma A Al-ZahraniDepartment of Chemistry, College of Sciences, University of Ha'il, Ha'il 2440, Saudi Arabia.
Subuhi SherwaniDepartment of Biology, College of Sciences, University of Ha'il, Ha'il 2440, Saudi Arabia.
Wahid A KhanDepartment of Clinical Biochemistry, College of Medicine, King Khalid University, Abha 61412, Saudi Arabia.
Ritika SahaDepartment of Biotechnology, Delhi Technological University, Delhi 110042, India.
Smita R VermaDepartment of Biotechnology, Delhi Technological University, Delhi 110042, India.
Nessar AhmedDepartment of Life Sciences, Manchester Metropolitan University, Manchester M1 5GD, UK.
University of Ha'il · SADelhi Technological University · INKing Khalid University · SAManchester Metropolitan University · GB

Funding

This research has been funded by Scientific Research Deanship at the University of Ha'il- Saudi Arabia RG-20 120.
6 · The paper itself

Abstract

Garlic has been reported to inhibit protein glycation, a process that underlies several disease processes, including chronic complications of diabetes mellitus. Biophysical, biochemical, and molecular docking investigations were conducted to assess anti-glycating, antioxidant, and protein structural protection activities of garlic. Results from spectral (UV and fluorescence) and circular dichroism (CD) analysis helped ascertain protein conformation and secondary structure protection against glycation to a significant extent. Further, garlic showed heat-induced protein denaturation inhibition activity (52.17%). It also inhibited glycation, advanced glycation end products (AGEs) formation as well as lent human serum albumin (HSA) protein structural stability, as revealed by reduction in browning intensity (65.23%), decrease in protein aggregation index (67.77%), and overall reduction in cross amyloid structure formation (33.26%) compared with positive controls (100%). The significant antioxidant nature of garlic was revealed by FRAP assay (58.23%) and DPPH assay (66.18%). Using molecular docking analysis, some of the important garlic metabolites were investigated for their interactions with the HSA molecule. Molecular docking analysis showed quercetin, a phenolic compound present in garlic, appears to be the most promising inhibitor of glucose interaction with the HSA molecule. Our findings show that garlic can prevent oxidative stress and glycation-induced biomolecular damage and that it can potentially be used in the treatment of several health conditions, including diabetes and other inflammatory diseases.

Indexed as

GarlicAntioxidantsGlycation End Products, AdvancedGlycosylationHumansMolecular Docking SimulationAntioxidantsGlycation End Products, AdvancedAGEsanti-glycationantioxidantgarlicglycationHSA

Identifiers

PMID35335232
PMCPMC8950752
OpenAlexW4220674673

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.